NewsBenzingaCartesian Therapeutics 在 2026 年 AANEM 年会 MGFA 科学会议上公布其领先在研资产 Descartes-08 在全身型 MG 患者中的更多再治疗数据 Cartesian Therapeutics 在 2026 年 AANEM 年会 MGFA 科学会议上公布其领先在研资产 Descartes-08 在全身型 MG 患者中的更多再治疗数据 Benzinga 2026.09.29 11:32 (GMT+0) Open on Benzinga Other news Barclays Maintains Equal-Weight on Exelon, Lowers Price Target to $44 The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition. Citizens Financial Analysts Slash Their Forecasts Following Q3 Results Barclays Maintains Overweight on Evergy, Lowers Price Target to $86 Mastercard Brings Its Fraud-Fighting Tools to Stablecoin Payments Barclays Maintains Overweight on Entergy, Lowers Price Target to $115
The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition.
